|

CX11 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: VCT220

Pipeline

Phase 2: 1

Top Sponsors

  • Corxel Pharmaceuticals1

Indications

  • Type II Diabetes Mellitus1
  • Weight Loss1
  • Diabetes1

Birmingham, Alabama1 trial

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Central Research Associates - Flourish - PPDS

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.